Simvastatin and ezetimibe reduce plasma lipoprotein binding to human arterial proteoglycans in gallstone diseased patients. (August 2018) - Littmann, K.; Ahmed, O.; Gustafsson, U.; Pramfalk, C.; Öörni, K.; Larsson, L.; Sahlin, S.; Camejo, G.; Parini, P.; Eriksson, M.